In conclusion, this study retrospectively compared the clinicopathological features and outcomes between the low C3 group and the normal C3 group, and found that patients with low serum C3 levels had a higher proportion of glomerular sclerosis progressing into kidney failure. The gene discussed is C3; the disease is Glomerular sclerosis.